Ocular surface disease in pediatric patients with moderate-to-severe atopic dermatitis

被引：0
作者：
van Der Rijst, Lisa P. [1 ,2 ]
Veldhuis, Nienke [2 ]
van Der Kamp, Sara [2 ]
Achten, Roselie E. [2 ]
van Luijk, Chantal M. [3 ]
Voskuil-Kerkhof, Elsbeth S. M. [3 ]
Haeck, Inge M. [2 ]
de Bruin-Weller, Marjolein S. [2 ]
de Graaf, Marlies [1 ,2 ]
机构：
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Dept Dermatol & Allergol,Wilhelmina Childrens Hosp, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Natl Expertise Ctr Atop Dermatitis, Dept Dermatol & Allergol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands
来源：
PEDIATRIC ALLERGY AND IMMUNOLOGY | 2025年 / 36卷 / 02期
关键词：
atopic dermatitis; children; conjunctivitis; ocular surface disease; pediatric; type; 2; inflammation; CHILDREN;
D O I：
10.1111/pai.70040
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review
    Shi, Vivian Y.
    Chamberlain, Winston
    Siegfried, Elaine
    Kraff-Cooper, Cheryl
    Beckman, Kenneth
    Lio, Peter
    Paller, Amy S.
    Simpson, Eric
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 309 - 315
  • [42] Advances in Systemic Treatment for Adults With Moderate-to-Severe Atopic Dermatitis
    Cho, Yung-Tsu
    Chu, Chia-Yu
    DERMATOLOGICA SINICA, 2019, 37 (01) : 3 - 11
  • [43] Comparative effectiveness of upadacitinib versus dupilumab for moderate-to-severe atopic dermatitis: A retrospective cohort study
    Yang, Yan
    Chen, Jiaoquan
    Xiong, Siyin
    Zhang, Jing
    Ye, Qianru
    Xue, Rujun
    Tian, Xin
    Zhong, Jiemin
    Zhu, Huilan
    Gao, Aili
    Liu, Yumei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [44] Ocular surface disease in atopic dermatitis
    Dogru, M
    Nakagawa, N
    Tetsumoto, K
    Katakami, C
    Yamamoto, M
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1999, 43 (01) : 53 - 57
  • [45] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
    Nettis, Eustachio
    Patella, Vincenzo
    Lombardo, Carla
    Detoraki, Aikaterini
    Macchia, Luigi
    Di Leo, Elisabetta
    Carbonara, Monica
    Canonica, Giorgio W.
    Bonzano, Laura
    ALLERGY, 2020, 75 (10) : 2653 - 2661
  • [46] Unveiling the true costs and societal impacts of moderate-to-severe atopic dermatitis in Europe
    Augustin, M.
    Misery, L.
    von Kobyletzki, L.
    Armario-Hita, J. C.
    Mealing, S.
    Redding, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 : 3 - 16
  • [47] Review of Prominent Cytokines as Superior Therapeutic Targets for Moderate-to-Severe Atopic Dermatitis
    Hassan, Zaira
    Luvsannyam, Enkhmaa
    Patel, Dhara
    Nukala, Swetha
    Puvvada, Suvarna Rekha
    Hamid, Pousettef
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [48] Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Ramien, Michele
    Tang, Mark
    Joyce, Joel C.
    Praestgaard, Amy
    Rossi, Ana B.
    Clearfield, Drew
    Zhang, Annie
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [49] Therapeutic Efficacy and Safety of Methotrexate in Moderate-to-Severe Atopic Dermatitis: A Retrospective Study of Korean Patients at Tertiary Referral Hospital
    Lee, Ji Hong
    Yun, Sook-Jung
    Lee, Jee-Bum
    Lee, Seung-Chul
    ANNALS OF DERMATOLOGY, 2020, 32 (05) : 402 - 408
  • [50] Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
    Adrien Maudinet
    Sandrine Law-Koune
    Claire Duretz
    Audrey Lasek
    Philippe Modiano
    Thi Ha Chau Tran
    Ophthalmology and Therapy, 2019, 8 : 485 - 490
12345